The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 ( voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells (Vol 30, pg 337, 2016)

Autor:	Thijssen, R., ter Burg, J., van Bochove, G. G. W., de Rooij, M. F. M., Kuil, A., Jansen, M. H., Kuijpers, T. W., Baars, J. W., Virone-Oddos, A., Spaargaren, M., Egile, C., van Oers, M. H. J., Eldering, E., Kersten, M. J., Kater, A. P.
Přispěvatelé:	Other departments, Amsterdam institute for Infection and Immunity, Cancer Center Amsterdam, Pathology, Paediatric Infectious Diseases / Rheumatology / Immunology, Landsteiner Laboratory, Clinical Haematology, Experimental Immunology
Jazyk:	angličtina
Rok vydání:	2016
Zdroj:	Leukemia, 30(9). Nature Publishing Group
ISSN:	0887-6924
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=narcis______::82f5a6e9173e99317e5d0708e483426f https://pure.amc.nl/en/publications/the-pan-phosphoinositide-3kinasemammalian-target-of-rapamycin-inhibitor-sar245409--voxtalisibxl765-blocks-survival-adhesion-and-proliferation-of-primary-chronic-lymphocytic-leukemia-cells-vol-30-pg-337-2016(a3c24e96-6a4d-4761-96b9-bbfed7fed413).html Zobrazit plný text záznamu Full text from SpringerLink